Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 August 1998 | Volume 129 Issue 3 | Pages 204-208
Background: Rare, monogenic forms of hypertension may give insight into novel mechanisms relevant to essential hypertension. Autosomal dominant hypertension with brachydactyly has been documented in a single Turkish kindred; the gene was mapped to chromosome 12p.
Objective: To describe the molecular genetics of additional families with autosomal dominant hypertension and brachydactyly.
Design: Case series.
Setting: Tertiary care medical centers.
Patients: An 11-member Canadian family and a 7-member U.S. family, neither of Turkish background, with autosomal dominant hypertension and type E brachydactyly.
Measurements: Clinical evaluation, genotyping, and haplotype analyses.
Results: The mode of inheritance, the type E brachydactyly, and the propensity for stroke were consistent with autosomal dominant hypertension with brachydactyly. The same markers on chromosome 12p cosegregated with the phenotype in the families. A haplotype analysis strongly supported the conclusion that these families have a molecular defect in the same gene.
Conclusions: The syndrome of autosomal dominant hypertension and brachydactyly is not confined to patients of Turkish origin. All persons with brachydactyly should have their blood pressure measured, and the syndrome should be considered if hypertension is found.
Author and Article Information
From The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Boston University Medical Center, Boston, Massachusetts; and Humboldt University of Berlin, Berlin, Germany.
BRIEF COMMUNICATION
Families with Autosomal Dominant Brachydactyly Type E, Short Stature, and Severe Hypertension
![]()
Grant Support: By a grant-in-aid to Friedrich C. Luft from the Bundesministerium fur Bildung und Forschung; a grant-in-aid from the U.S. Air Force; and Perkin-Elmer, Applied Biosystems Division (Foster City, California). Astra Hassle Corp. (Wedel, Germany) supplied the antihypertensive medications. This study partly satisfies the research requirements for the Dr. med. degree of Hakan R. Toka.
Requests for Reprints: Friedrich C. Luft, MD, Franz Volhard Clinic, Wiltberg Strasse 50, 13122 Berlin, Germany.
Current Author Addresses: Drs. Toka, Bahring, Wienker, Schuster, and Luft, Ms. Jeschke, and Mr. Toka: Franz Volhard Clinic, Wiltberg Strasse 50, 13122 Berlin, Germany.
This article has been cited by other articles:
![]() |
S. Bahring, M. Kann, Y. Neuenfeld, M. Gong, D. Chitayat, H. R. Toka, O. Toka, G. Plessis, P. Maass, A. Rauch, et al. Inversion Region for Hypertension and Brachydactyly on Chromosome 12p Features Multiple Splicing and Noncoding RNA Hypertension, February 1, 2008; 51(2): 426 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bahring, A. Rauch, O. Toka, C. Schroeder, C. Hesse, H. Siedler, G. Fesus, W. E. Haefeli, A. Busjahn, A. Aydin, et al. Autosomal-Dominant Hypertension With Type E Brachydactyly Is Caused by Rearrangement on the Short Arm of Chromosome 12 Hypertension, February 1, 2004; 43(2): 471 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft, O. Toka, H. R. Toka, J. Jordan, and S. Bahring Mendelian hypertension with brachydactyly as a molecular genetic lesson in regulatory physiology Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R709 - R714. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft Mendelian Forms of Human Hypertension and Mechanisms of Disease Clin. Med. Res., October 1, 2003; 1(4): 291 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gong, H. Zhang, H. Schulz, Y.-A. Lee, K. Sun, S. Bahring, F. C. Luft, P. Nurnberg, A. Reis, K. Rohde, et al. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p Hum. Mol. Genet., June 1, 2003; 12(11): 1273 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft Molecular Genetics of Salt-Sensitivity and Hypertension Drug Metab. Dispos., April 1, 2001; 29(4): 500 - 504. [Abstract] [Full Text] |
||||